Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Rapoport

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|August 20, 2016
The Clinical Problem of Chemotherapy-Induced Nausea and VomitingBernardo Rapoport
Expert Opinion on Drug Safety|May 3, 2017
Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapyBernardo Rapoport, Teresa Smit
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 26, 2013
The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropeniaJean Klastersky, Harry Raftopoulos, Bernardo Rapoport
International Journal of Women'S Dermatology|January 10, 2022
Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for managementZoe Apalla, Bernardo Rapoport, Vincent Sibaud
Expert Review of Clinical Pharmacology|November 30, 2016
Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapyBernardo Rapoport, Ronwyn van Eeden, Teresa Smit
Future Oncology (London, England)|May 23, 2019
Meta-analysis comparing incidence of grade 3-4 neutropenia with ALK inhibitors and chemotherapy in patients with non-small-cell lung cancerBernardo Rapoport, Ramin B Arani, Nicola Mathieson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2011
Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapyPaul J Hesketh, Snezana M Bosnjak, Vlada Nikolic, et al.
Clinical Colorectal Cancer|September 17, 2008
Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trialsKimberly A Bauer, Scott Hammerman, Bernardo Rapoport, et al.
Emergency Cancer Care|July 18, 2022
Emergency management of incidental pulmonary embolism (IPE)Carme Font, Tim Cooksley, Shin Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 28, 2010
Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statementLawrence H Einhorn, Steven M Grunberg, Bernardo Rapoport, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|August 20, 2016
The Clinical Problem of Chemotherapy-Induced Nausea and VomitingBernardo Rapoport
Expert Opinion on Drug Safety|May 3, 2017
Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapyBernardo Rapoport, Teresa Smit
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 26, 2013
The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropeniaJean Klastersky, Harry Raftopoulos, Bernardo Rapoport
International Journal of Women'S Dermatology|January 10, 2022
Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for managementZoe Apalla, Bernardo Rapoport, Vincent Sibaud
Expert Review of Clinical Pharmacology|November 30, 2016
Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapyBernardo Rapoport, Ronwyn van Eeden, Teresa Smit
Future Oncology (London, England)|May 23, 2019
Meta-analysis comparing incidence of grade 3-4 neutropenia with ALK inhibitors and chemotherapy in patients with non-small-cell lung cancerBernardo Rapoport, Ramin B Arani, Nicola Mathieson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2011
Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapyPaul J Hesketh, Snezana M Bosnjak, Vlada Nikolic, et al.
Clinical Colorectal Cancer|September 17, 2008
Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trialsKimberly A Bauer, Scott Hammerman, Bernardo Rapoport, et al.
Emergency Cancer Care|July 18, 2022
Emergency management of incidental pulmonary embolism (IPE)Carme Font, Tim Cooksley, Shin Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 28, 2010
Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statementLawrence H Einhorn, Steven M Grunberg, Bernardo Rapoport, et al.
Pageof 4